Zamaneh Kassiri Selected Research

Tissue Inhibitor of Metalloproteinases

10/2018	Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts.
1/2016	Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
7/2014	Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
9/2012	Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.
11/2011	Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
8/2010	Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zamaneh Kassiri Research Topics

Disease

31	Fibrosis (Cirrhosis) 10/2021 - 03/2007
23	Inflammation (Inflammations) 01/2022 - 01/2006
19	Hypertrophy 01/2020 - 03/2002
17	Heart Failure 12/2018 - 10/2004
11	Myocardial Infarction 01/2022 - 09/2009
9	Hypertension (High Blood Pressure) 01/2020 - 05/2009
8	Heart Diseases (Heart Disease) 12/2018 - 02/2005
7	Cardiomyopathies (Cardiomyopathy) 01/2018 - 07/2007
7	Cardiomegaly (Heart Hypertrophy) 04/2015 - 03/2007
6	Neoplasms (Cancer) 01/2021 - 04/2006
6	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2018 - 10/2004
6	Infarction (Infarctions) 08/2017 - 09/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 08/2010
5	Iron Overload 01/2018 - 12/2015
4	Obesity 01/2021 - 01/2016
3	Rupture 01/2022 - 10/2010
3	Disease Progression 01/2022 - 03/2010
3	Aortic Aneurysm (Aneurysm, Aortic) 01/2022 - 12/2019
3	Abdominal Aortic Aneurysm 01/2020 - 12/2012
3	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2016
3	Vascular Diseases (Vascular Disease) 01/2019 - 01/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 09/2009
3	Reperfusion Injury 01/2017 - 11/2010
2	Wounds and Injuries (Trauma) 01/2022 - 01/2020
2	Atrophy 01/2021 - 12/2005
2	Atrial Fibrillation 01/2020 - 01/2014
2	Fatty Liver 01/2019 - 01/2017
2	Liver Diseases (Liver Disease) 01/2017 - 02/2016
2	Insulin Resistance 01/2017 - 01/2016
2	Hemochromatosis (Bronze Diabetes) 01/2017 - 02/2016
2	Body Weight (Weight, Body) 01/2016 - 04/2015
2	Ischemia 07/2014 - 11/2010
2	Ventricular Remodeling 09/2009 - 03/2007

Drug/Important Bio-Agent (IBA)

23	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 02/2005
20	Angiotensin IIIBA 01/2022 - 07/2007
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
10	Metalloproteases (Metalloproteinases)IBA 01/2022 - 05/2009
10	CollagenIBA 01/2022 - 09/2009
9	DisintegrinsIBA 01/2022 - 05/2009
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 08/2005
7	Tissue Inhibitor of Metalloproteinase-3IBA 10/2018 - 10/2004
6	EnzymesIBA 01/2020 - 04/2006
6	Tissue Inhibitor of MetalloproteinasesIBA 10/2018 - 08/2010
6	CytokinesIBA 01/2018 - 08/2005
6	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2016 - 11/2010
6	Angiotensin-Converting Enzyme 2IBA 07/2014 - 09/2009
5	Fibronectins (Fibronectin)IBA 01/2022 - 09/2009
5	IronIBA 01/2018 - 12/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2015 - 09/2009
4	AngiotensinsIBA 01/2022 - 07/2007
4	LipidsIBA 01/2017 - 12/2007
4	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2014 - 07/2007
4	Irbesartan FDA LinkGeneric 06/2012 - 07/2007
3	Tissue Inhibitor of Metalloproteinase-4IBA 01/2021 - 07/2014
3	CholesterolIBA 01/2021 - 04/2015
3	Fibrillar CollagensIBA 01/2021 - 01/2017
3	Phosphatidylethanolamine N-MethyltransferaseIBA 01/2019 - 01/2016
3	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2018 - 02/2011
3	ResveratrolIBA 01/2018 - 12/2015
3	Triglycerides (Triacylglycerol)IBA 01/2017 - 03/2013
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 07/2012
3	Therapeutic UsesIBA 02/2016 - 03/2014
3	angiotensin I (1-7)IBA 09/2015 - 06/2012
3	Oxidoreductases (Dehydrogenase)IBA 04/2015 - 09/2009
3	Superoxides (Superoxide)IBA 08/2014 - 03/2010
3	Glucose (Dextrose)FDA LinkGeneric 03/2014 - 07/2012
2	Peptides (Polypeptides)IBA 01/2022 - 07/2014
2	ReninIBA 01/2022 - 07/2012
2	GelsolinIBA 10/2021 - 12/2018
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2019 - 07/2012
2	ApelinIBA 01/2019 - 07/2013
2	AntioxidantsIBA 01/2019 - 02/2016
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019 - 07/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 09/2009
2	GelatinasesIBA 01/2018 - 09/2009
2	AcidsIBA 01/2017 - 01/2016
2	Epoxide HydrolasesIBA 01/2017 - 01/2016
2	Sirtuin 1IBA 02/2016 - 12/2015
2	Messenger RNA (mRNA)IBA 01/2016 - 07/2014
2	CalciumIBA 01/2016 - 03/2002
2	ElementsIBA 11/2015 - 04/2015
2	SterolsIBA 11/2015 - 04/2015
2	Secretory Phospholipases A2IBA 11/2015 - 03/2015
2	ChemokinesIBA 04/2015 - 09/2009
2	Insulin (Novolin)FDA Link 03/2015 - 03/2014
2	Biomarkers (Surrogate Marker)IBA 07/2014 - 09/2012
2	Cysteine (L-Cysteine)FDA Link 07/2014 - 11/2011
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2014 - 06/2012
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2014 - 06/2013
2	NADP (NADPH)IBA 06/2013 - 09/2009
2	Phosphotransferases (Kinase)IBA 02/2011 - 12/2007
2	ProcollagenIBA 02/2011 - 12/2009
2	Gq-G11 GTP-Binding Protein alpha Subunits (Gq Protein)IBA 01/2011 - 05/2009
2	Matrix Metalloproteinase InhibitorsIBA 10/2010 - 08/2005
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2010 - 10/2009
2	Procollagen Type IIBA 08/2010 - 12/2009
2	Collagenases (Collagenase)FDA Link 03/2010 - 07/2007

Therapy/Procedure

11	Therapeutics 01/2019 - 08/2005
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2007
2	Ligation 08/2017 - 09/2009